1 not yet recruiting, 1 unknown, 1 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Enteral Feeding Intolerance: new trials by email Literature Review of Enteral Feeding Intolerance trials Research Report on Enteral Feeding Intolerance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Evaluation of Mosapride Versus Metoclopramide for Enteral Feeding Intolerance in Critically Ill Patients Mosapride Citrate Tablets, Metoclopramide 10mg - Enteral Feeding Intolerance | Phase 3 | Not yet recruiting | Ain Shams University | 100 | 2025-02-01 | 2025-02-17 |
| Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit Amoxicillin, Placebo - Enteral Feeding Intolerance | Phase 2 / Phase 3 | Unknown | Sohag University | 90 | 2023-04-24 | 2023-04-26 |
| Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates Numeta G13%E, Compounded Parenteral Nutrition (cPN) solution - Malnutrition, Infant, Enteral Feeding Intolerance | Phase 3 | Withdrawn | Baxter Healthcare Corporation | 2021-08-20 | 2025-04-24 |
Hyperphagia (1) · Infant Nutrition Disorders (1)
Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Amoxicillin (1) · Metoclopramide (1) · Solutions (1) · mosapride (1)
Ain Shams University (1) · Baxter Healthcare Corporation (1) · Sohag University (1)
Egypt (2)